Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Liberty Media Corporation Series C Liberty Formula One Common Stock (FWONK) vs Liquidia Corporation Common Stock (LQDA) Price & Performance

Liberty Media Corporation Series C Liberty Formula One Common StockTrade
Liquidia Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Liberty Media Corporation Series C Liberty Formula One Common Stock vs Liquidia Corporation Common Stock — how do they compare? Liberty Media Corporation Series C Liberty Formula One Common Stock trades at $90.85 (market cap $23.11B), while Liquidia Corporation Common Stock trades at $34.26 (market cap $2.40B). The key difference: Liberty Media Corporation Series C Liberty Formula One Common Stock is far larger — about 9.6× Liquidia Corporation Common Stock's market cap, and Liberty Media Corporation Series C Liberty Formula One Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liberty Media Corporation Series C Liberty Formula One Common Stock for 0 Days and Liquidia Corporation Common Stock for 0 Days on average.

FWONKLQDA
Market Cap
$23.11B$2.40B
Volume
3,394,5962,857,547
Sector
MediaHealth
52-Week High
$106.66$91.03
52-Week Low
$81.42$22.02
Typical Hold Time
0 Days0 Days
Enterprise Value
$26.57B$2.30B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FWONK
100% Buy0% Sell
Avg holding period · 0 Days
LQDA
62% Buy38% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Liberty Media Corporation Series C Liberty Formula One Common Stock

Liberty Media Corporation's Series C Liberty Formula One common stock is a tracking stock reflecting the economic performance of the Formula One Group, which holds Liberty Media's interests in Formula 1 racing, MotoGP, and related minority investments.

Read more on FWONK →

About Liquidia Corporation Common Stock

Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.

Read more on LQDA →